NYSE · RERE
ATRenew financials
$3.80−1.30%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $3.01B | $2.24B | $1.83B | $1.43B | $1.22B |
| Gross profit | $369.7M | $254.8M | $212.3M | $1.43B | $1.22B |
| Gross margin | 12.3% | 11.4% | 11.6% | 100.0% | 100.0% |
| Operating income | $65.2M | $4.0M | -$24.5M | -$380.4M | -$140.8M |
| Net income | $48.1M | -$1.1M | -$22.1M | -$357.8M | -$208.5M |
| Net margin | 1.6% | −0.1% | −1.2% | −25.0% | −17.0% |
| Diluted EPS | $0.30 | $-0.01 | $-0.14 | $-2.20 | $-2.16 |
| EBITDA | $81.8M | $40.6M | $22.7M | -$57.7M | -$82.0M |
| Operating cash flow | -$59.3M | $88.1M | $34.5M | $127.8M | -$160.2M |
| Free cash flow | -$79.9M | $79.9M | $22.4M | $118.9M | -$171.8M |
| Diluted shares | 162.2M | 161.6M | 162.2M | 162.8M | 96.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $219.8M | $269.9M | $279.5M | $247.0M | $212.8M |
| Short-term investments | $38.3M | $80.0M | $58.0M | $113.4M | $80.1M |
| Total debt | $46.1M | $30.8M | $49.4M | $18.0M | $14.9M |
| Total assets | $852.7M | $697.4M | $776.0M | $731.9M | $1.18B |
| Total liabilities | $282.4M | $191.3M | $251.7M | $169.2M | $169.8M |
| Shareholders' equity | $570.4M | $506.2M | $524.3M | $562.7M | $1.01B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology